Participants 412 558 6
patients (n=209 MG, n=96 placebo) with UC in remission [revised Sutherland Disease Activity Index (SDAI) rectal bleeding=0, mucosal appearance <2]
Participants 559 616 6
who took MG 1.5 g or placebo once-daily for up to 6 month
Participants 889 952 3
The percentage of relapse-free patients at month 6/end of treat
